Polyglycan, the novel formulation made up of hyaluronic acid, chondroitin sulfate, and N-acetyl-D-glucosamine (HACSAG), is labeled for intra-articular post-surgical lavage and replacement of synovial fluid. It is not currently marketed or approved as a drug in the United States, although it is manufactured here in an FDA-inspected and -approved facility. Treatment goals for osteoarthritis are to
To continue reading this article, become a member of TheHorse.com.
It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.
